|  Help  |  About  |  Contact Us

Publication : Selective effects of NF-κB1 deficiency in CD4⁺ T cells on Th2 and TFh induction by alum-precipitated protein vaccines.

First Author  Serre K Year  2011
Journal  Eur J Immunol Volume  41
Issue  6 Pages  1573-82
PubMed ID  21469117 Mgi Jnum  J:176487
Mgi Id  MGI:5291904 Doi  10.1002/eji.201041126
Citation  Serre K, et al. (2011) Selective effects of NF-kappaB1 deficiency in CD4 T cells on Th2 and TFh induction by alum-precipitated protein vaccines. Eur J Immunol 41(6):1573-82
abstractText  NF-kappaB1-dependent signaling directs the development of CD4(+) Th2 cells during allergic airway inflammation and protective responses to helminth infection. Here, we show that IL-4 and IL-13 production is NF-kappaB1-dependent in mouse OVA-specific CD4(+) (OTII) T cells responding to alum-precipitated OVA (alumOVA) immunization. More surprisingly, we found that NF-kappaB1 deficiency in OTII cells also selectively impairs their CXCR5 induction by alumOVA without affecting upregulation of BCL6, IL-21, OX40 and CXCR4 mRNA and PD-1 protein. This results in functional impairment of follicular helper T cells. Thus, fewer germinal center B cells develop in LN responses to alumOVA in T-cell-deficient mice reconstituted with NF-kappaB1(-/-) OTII cells as opposed to NF-kappaB1(+/+) OTII cells, while plasma cell numbers are comparable. Unlike CXCR5 induction in CD4(+) T cells, NF-kappaB1-deficient recirculating follicular B cells are shown to express normal levels of CXCR5. The selective effects of NF-kappaB1-deficiency on Th2 and follicular helper T cell induction do not appear to be due to altered expression of the Th2-associated transcription factors - GATA-3, c-Maf and Ikaros. Altogether, these results suggest that NF-kappaB1 regulates the expression of CXCR5 on CD4(+) T cells primed in vivo, and thus selectively controls the T-cell-dependent germinal center component of B-cell response to alumOVA.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression